The feverish diseases dengue and chikungunya could soon become endemic in Europe as the tiger mosquitoes that transmit these ...

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...

The US Centers for Disease Control and Prevention (CDC) is warning people planning to travel to the Region of the Indian ...

Both the FDA and EMA have suspended Ixchiq’s use in older adults after post-marketing serious adverse events that include two ...

The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...

Federal drug safety officials have recommended pausing the use of a vaccine for a mosquito-borne disease known as chikungunya for people over 60 following reports of serious adverse events.

According to reports, a cause for concern is that 51 of the cases involve infants under one year of age, while 553 are among ...

Chikungunya, caused by its namesake virus ... there is a risk of disease transmission to travellers visiting outbreak-affected countries in Africa and South America, along with islands in the ...